ABT


Line plots across dimensions of each concept
Tables

Table of contents



us-gaap:CommonStockValue

us-gaap:CommonStockSharesIssued
us-gaap:StatementEquityComponents
us-gaap:CommonStockSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments, us-gaap:Subsegments
us-gaap:StatementGeographical
us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments
us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments, us-gaap:Subsegments

us-gaap:CostOfGoodsAndServicesSold

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:InterestExpense

us-gaap:CostsAndExpenses

us-gaap:ResearchAndDevelopmentExpense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:OperatingIncomeLoss
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:InterestExpense

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

us-gaap:IncomeTaxExpenseBenefit

us-gaap:ProfitLoss

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

us-gaap:Assets

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:ShortTermInvestments

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:LongTermInvestments
us-gaap:FairValueByMeasurementBasis, us-gaap:InvestmentType
us-gaap:InvestmentType

us-gaap:Goodwill
us-gaap:StatementBusinessSegments

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:LiabilitiesCurrent

us-gaap:LongTermDebtCurrent

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:AccruedIncomeTaxesCurrent

us-gaap:DividendsPayableCurrent
us-gaap:DebtInstrument, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:LongTermDebt

us-gaap:LongTermDebtNoncurrent

us-gaap:MinorityInterest

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:MinorityInterest

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:ProfitLoss

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet

us-gaap:IncreaseDecreaseInInventories

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:RepaymentsOfLongTermDebt

us-gaap:PaymentsOfDividendsCommonStock

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:RepaymentsOfLongTermDebt

us-gaap:ShareBasedCompensation

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:ProceedsFromRepaymentsOfShortTermDebt

abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems
abt:CorporateAndBenefitPlanCosts
us-gaap:StatementEquityComponents
abt:EffectOfCommonAndTreasuryShareTransactions

abt:IncomeLossFromContinuingOperationsAllocatedToCommonShares
us-gaap:StatementEquityComponents
abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations
us-gaap:ConsolidationItems
abt:OtherCostAndExpenseOperatingAndNonoperating
us-gaap:RestructuringCostAndReserve
abt:RestructuringReservePeriodCashSettledAndOtherAdjustments
us-gaap:ConsolidationItems
us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AmortizationOfIntangibleAssets

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CommonStockDividendsPerShareDeclared
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanContributionsByEmployer
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanInterestCost
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanServiceCost

us-gaap:Depreciation
us-gaap:StatementEquityComponents
us-gaap:DividendsCommonStockCash

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
us-gaap:ConsolidationItems
us-gaap:InterestIncomeExpenseNet

us-gaap:InvestmentIncomeInterest

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
us-gaap:StatementEquityComponents
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax

us-gaap:PaymentsForOtherTaxes

us-gaap:PaymentsForProceedsFromInvestments

us-gaap:PaymentsForProceedsFromOtherInvestingActivities

us-gaap:ProceedsFromStockOptionsExercised
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
us-gaap:HedgingDesignation
us-gaap:StatementEquityComponents
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap:IncomeStatementLocation, us-gaap:RestructuringCostAndReserve
us-gaap:RestructuringCharges
us-gaap:RestructuringCostAndReserve
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap:StatementOperatingActivitiesSegment
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockSharesAcquired
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockValueAcquiredCostMethod

abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities

abt:PrepaidExpenseAndOtherReceivables

us-gaap:AccountsPayableTradeCurrent

us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax

us-gaap:AllowanceForDoubtfulAccountsReceivable
us-gaap:Restatement, us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent

us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AvailableForSaleSecurities
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BusinessCombinationContingentConsiderationLiability
us-gaap:FairValueByMeasurementFrequency

us-gaap:ContractWithCustomerLiability
us-gaap:Range
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible

us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent

us-gaap:DerivativeFairValueOfDerivativeAsset
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:DerivativeFairValueOfDerivativeLiability
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:DerivativeNotionalAmount
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization

us-gaap:FiniteLivedIntangibleAssetsGross
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
us-gaap:FairValueByMeasurementBasis
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:HedgedLiabilityFairValueHedge
us-gaap:FairValueByMeasurementFrequency

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:InterestRateDerivativeAssetsAtFairValue
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementBasis
us-gaap:InterestRateFairValueHedgeAssetAtFairValue

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryRawMaterialsNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:LiabilitiesFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementBasis
us-gaap:LongTermDebtFairValue
us-gaap:Range, us-gaap:LossContingenciesByNatureOfContingency
us-gaap:LossContingencyEstimateOfPossibleLoss
us-gaap:RestructuringCostAndReserve
us-gaap:RestructuringReserve
us-gaap:StatementBusinessSegments
us-gaap:RevenueRemainingPerformanceObligation

us-gaap:ShortTermBorrowings

us-gaap:TreasuryStockCommonShares

us-gaap:TreasuryStockCommonValue

Tables

  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:CommonStockValue ████████████▇▂▂▁▁▁▁▁▁▁▁▁▁▁2373123853237712366523461235122342823317232232320623118230122288613027129391283512744127341264112566124621238312207121261203212048NANANA11755NANANANANA900588428744NANANA8257NANANA7444NANANA
us-gaap:CommonStockSharesIssued █████████████▃▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▁▁▁▁▁19781976197619761973197119701969196919651964196219601707170617051704170217001699169816941692169116891685168216811678167516701659165216381626162516231619NANANA1612NANANA1601NANANA
 us-gaap:CommonStockSharesOutstanding us-gaap:StatementEquityComponents us-gaap:CommonStock█▇▇▇▅▄▄▃▃▁1978197619761976197319711970196919691965NANANA1707NANANA1702NANANA1694NANANA1685NANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:CommonStockSharesOutstanding us-gaap:StatementEquityComponents us-gaap:TreasuryStockCommon▂▄▁▁▂▄▄▄▅█209214208208209215214215216222NANANA234NANANA229NANANA186NANANA137NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding 1780NA178417811776NA177117681765NA175417481735NA147614801483NA150515041515NA151915171547NA156615761586NA159415881589NA156815661558NA155415511561NANANANANANANANA
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic 1768NA177117681763NA175917571753NA174317401727NA147614741477NA149514931504NA150815061532NA155115601568NA157615721573NA155815561551NA154515441547NANANANANANANANA
us-gaap:EarningsPerShareBasic ▄▅▅▅▄▄▄▄▄▁▄▃▄▅▂▄▃▄▄▄█▅▄▄▄▄▅▄▄▅▇▆▅▆▃▇▅▆▅▆▅▆▆▆▆▆▅▆▅0.320.590.540.570.380.370.320.420.24-0.480.340.160.240.54-0.220.410.210.510.390.521.520.590.360.30.240.380.620.30.350.661.221.090.791.030.191.240.560.930.580.830.650.990.950.830.930.990.70.860.61
us-gaap:EarningsPerShareDiluted ▄▅▅▅▄▄▄▄▃▁▄▃▄▅▂▄▃▄▄▅█▅▄▄▄▄▅▄▄▅▇▆▅▆▃▇▅▆▅▆▅▆▆▆▆▆▅▆▅0.310.590.530.560.380.370.320.410.23-0.480.340.160.240.53-0.220.410.210.510.380.521.510.590.360.30.240.370.610.30.340.661.211.080.781.020.191.230.550.920.570.830.640.980.950.830.920.980.690.850.6
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare ▆███▇▇▆▇▆▁▆▅▆▇▃▇▄▇▇█▆▇▆▆▆▇▇▆▆▂▆▆▆0.310.590.540.570.380.370.310.410.23-0.50.320.150.220.51-0.240.40.040.460.40.520.350.420.290.30.220.380.50.30.35-0.330.210.260.22NANANANANANANANANANANANANANANANA
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare ▆███▇▇▆▇▆▁▆▅▆▇▃▇▄▇▇█▆▇▆▆▆▇▇▆▆▂▆▆▆0.30.590.530.560.380.370.310.40.23-0.50.320.150.220.51-0.240.40.040.460.390.520.350.410.290.30.220.370.490.30.34-0.330.210.260.22NANANANANANANANANANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▄▅▅▅▄▄▄▄▄▄▃▃▃▂▁▂▁▁▁▁▁▂▁▂▁▂▂▂▂█▇▇▆▇▇▇▆▇▅▆▄▆▄▄▃▅▄▄▃772683148076797975357765765677677390758968296637633553335302533348855188515051704897535651045551524456555369544653771083697739807945610377981696169040996786748826769887907761749467187950749773146765
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems us-gaap:OperatingSegments7711NA739573616954NA712472816960NA644262855853NA468847284362NA457845934357NA446849014637NA419848084762NANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:DiagnosticProducts1826NA190919051841NA182418731837NA127912731158NA121312261118NA115611771093NA118011891117NA112511351088NANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:EstablishedPharmaceuticalProducts1044NA12121108992NA115911291044NA11711021950NA1012980888NA961977897NA77112161151NA69112181233NANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:MedicalDevices2937NANANA2895NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:NutritionalProducts1904NA187418751792NA183818581756NA176817311642NA175517401671NA178917171669NA178717311631NA163517041699NANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments abt:DiagnosticProducts1826NA190919051841NA182418731837NA127912731158NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments abt:EstablishedPharmaceuticalProducts1044NA12121108992NA115911291044NA11711021950NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments abt:MedicalDevices2937NANANA2895NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments abt:NutritionalProducts1904NA187418751792NA183818581756NA176817311642NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments,us-gaap:Subsegments abt:DiagnosticProducts,abt:CoreLaboratory989NA117711691061NA108611281019NA10331020911NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments,us-gaap:Subsegments abt:EstablishedPharmaceuticalProducts,abt:KeyEmergingMarkets813NA891853752NA866866793NA885798730NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments,us-gaap:Subsegments abt:NutritionalProducts,abt:AdultNutritionals815NA830824763NA799807762NA793744715NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments,us-gaap:Subsegments abt:NutritionalProducts,abt:PediatricNutritionals1089NA104410511029NA10391051994NA975987927NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical country:US2856NA283428502754NA270727022675NA231323602324NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical us-gaap:NonUs4870NA524251294781NA494950654715NA451642774011NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments country:US,abt:DiagnosticProducts803NA702695724NA666652700NA369385NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments country:US,abt:MedicalDevices1233NANANA1275NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments country:US,abt:NutritionalProducts812NA788786747NA774781758NA759773NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments us-gaap:NonUs,abt:DiagnosticProducts1023NA120712101117NA115812211137NA910888NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments us-gaap:NonUs,abt:EstablishedPharmaceuticalProducts1044NA12121108992NA115911291044NA11711021NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments us-gaap:NonUs,abt:MedicalDevices1704NANANA1620NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments us-gaap:NonUs,abt:NutritionalProducts1092NA108610891045NA10641077998NA1009958NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical,us-gaap:StatementBusinessSegments,us-gaap:Subsegments us-gaap:NonUs,abt:EstablishedPharmaceuticalProducts,abt:KeyEmergingMarkets813NA891853752NA866866793NA885798NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:CostOfGoodsAndServicesSold 3281NA335832793160NA316632823067NA28763189NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:SellingGeneralAndAdministrativeExpense 2548NA244024342478NA237724662542NA209921322424NA162817371698NA166617271737NA160317881762NA173417141785NA292129443000NA423827622850NA267327432162NANANANANANANANA
us-gaap:InterestExpense 139NA167168171NA203210227NA218214226NA11710358NA414437NA353939NA394040NA152127126NA124134145NA149134118NANANANANANANANA
us-gaap:CostsAndExpenses 6968NA687867736796NA666168856782NA601962106537NA440545174361NA443744414287NA437347904793NA473848184763NA778477027880NA922178427739NA749372206227NANANANANANANANA
us-gaap:ResearchAndDevelopmentExpense 578NA596577672NA574575589NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:SellingGeneralAndAdministrativeExpense 2548NA244024342478NA237724662542NA209921322424NA162817371698NA166617271737NA160317881762NA173417141785NA292129443000NA423827622850NA267327432162NANANANANANANANA
us-gaap:OperatingIncomeLoss 758NA11981206739NA995882608NA810427-202NA897816524NA713729610NA731761451NA630627614NA198921041575NA59417731301NA118116051470NANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:ConsolidationItems us-gaap:OperatingSegments1848NA189218711667NA189718821699NA170915991491NA119911381004NA118211451077NA11191044NANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:DiagnosticProducts405NA456466434NA443489443NA353338284NA301288267NA307304276NA310279NANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:EstablishedPharmaceuticalProducts181NA281214159NA289208167NA271180140NA211192148NA177172167NA160160NANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:MedicalDevices803NANANA847NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OperatingIncomeLoss us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,abt:NutritionalProducts459NA414447380NA435424365NA403392351NA438368342NA459389350NA369302NANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:InterestExpense 139NA167168171NA203210227NA218214226NA11710358NA414437NA353939NA394040NA152127126NA124134145NA149134118NANANANANANANANA
us-gaap:OtherNonoperatingIncomeExpense 1NA553847NA-187833NA-8391126NA-972-8-19NA32795NA3-3-3NA267-5NA10-871NA55-140NA-4810NANANANANANANANA
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest 633NA11031102632NA718777431NA626295736NA-1797152NA714986653NA718737423NA628600554NA187220031513NA50116741068NANANANANANANANANANANANA
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest ▆███▇▇▆▇▆▁▆▅▆▇▃▆▄▇▆▇▆▆▆▆▅▆▇▆▆▂▅▆▅54410499601006672655552718409-864561270386875-35759956695596786529634440460339589772476544-522338410351NANANANANANANANANANANANANANANANA
us-gaap:IncomeTaxExpenseBenefit 89NA14396-40NA1665922NA6525350NA178116-54NA118200124NA27827784NA-1441249NA-70278270NA198-268204NA173267319NANANANANANANANA
us-gaap:ProfitLoss 564NANANA672NANANA418NANANA419NANANANANANANANANANANANANANANANA1053194217241242161830319428631440890129110031538148012881438153610841322937
us-gaap:ComprehensiveIncomeNetOfTax -357NA5621111788NA467-447742NA7375651001NA361243123NA-162713871611NANANANANANANANANANANANANA-113523392413NA2038-362-827NANANANANANANANA
us-gaap:NetIncomeLoss ▄▅▅▅▄▄▄▅▄▁▄▃▄▅▂▄▄▅▄▅█▅▄▄▄▄▅▄▄▅▇▇▆56410499601006672654563733418-828603283419798-32961531676758078422929055384663755899664765451053194317251242NANANANANANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings564NA9601006672NA563733418NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic 561NA9541000668NA560730415NA601281417NA-329612315NA5777802281NA536463373NA965476544NA194217241242NA3031942863NA890NANANANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:Assets ▆▆▇▇▆▆▇▇▇█▇▇▇▄▁▁▁▁▁▂▂▁▂▁▁▂▂▂▂▆▆▅▅▅▅▅▅▅6677767887685396842767610671737163768415709087625072248711517088752666394973983139637412474172544125430954127542514414754166242953441324290342686672346325761859624156027659628620046165159462NANANA52416NANANA42419NANANA
us-gaap:LiabilitiesAndStockholdersEquity ▆▆▇▇▆▆▇▇▇█▇▇▇▄▁▁▁▁▁▂▂▁▂▁▁▂▂▂▂▆▆▅▅▅▅▅▅▅6677767887685396842767610671737163768415709087625072248711517088752666394973983139637412474172544125430954127542514414754166242953441324290342686672346325761859624156027659628620046165159462NANANA52416NANANA42419NANANA
us-gaap:StockholdersEquity ▇▇██▇▇▇▇█▇███▁▁▁▁▁▁▃▂▂▂▃▃▄▃▂▂▅▅▃▄▃▃▅▃▂3021831088318173168630925305243070530577313993089732032316023136220538207762067520722212112111123008218742152622888236022339025171236962233622588267202701424486254532443924603263782462922388NANANA22855NANANA17479NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:AssetsCurrent ▂▂▂▂▂▂▃▂▂▄▄▄▄▆▁▁▁▂▂▄▄▂▃▃▃▄▄▄▃█▆▆▆▅▅▅▅▅1549815667161191519514409146321819614122149642014721377199831932926776129781298812406141551589421131199851526116464182581793119247197481983119096313222726426257256022376823094241322364722317NANANA23313NANANA17042NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▂▂▂▂▂▂▃▂▂▄▅▄▄█▁▁▂▂▂▂▂▂▂▂▁▂▂▃▂▅▄▃▂▃▂▂▁▂▂▂▁▄337738604091313730223844736930653857940711012967587061862025002578333450013132404832264063361335702060347528825572437310802799670524345681250494077274036483818432115668809NANANA4112NANANA
us-gaap:ShortTermInvestments ▁▁▁▁▁▁▁▁▁▁▁▁▁▁▃▃▁▂▄█▇▁▂▄▆▅▇▅▅▅▄▅▆▂▄▆▅▃2912802442392392421811991852031871601541552007186062311243007712966233971264349249874623572338214144437135073949518012842927481637621803NANANA1122NANANA967NANANA
us-gaap:AccountsReceivableNetCurrent ▄▄▄▅▄▄▄▄▄▄▃▃▃▁▁▂▁▁▁▁▁▂▂▂▂▂▂▂▂█▇▇██▇▇▇▇52925425545055485345518252715192535652494800463345103248332035673430341834603553348135863618405638833986388239383917761269486767765976837043703871607184NANANA6541NANANA5465NANANA
us-gaap:InventoryNet █▇▇▇▆▅▅▅▆▅▄▅▆▁▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▅▆▅▅▄▄▄▄▃45684316439243524085379637813714382636013483360339952434261328132786259926332735262326432696282327752693280427252710379238143518354932843269347534003188NANANA3264NANANA2775NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:PropertyPlantAndEquipmentGross ▆▆▅▅▅▅▄▄▄▄▄▃▃▁▁▁▁▁▁▁▁▁▁▂▂▂▁▁▁██▇▇▇▇▇▆▆1670716799163431633115905157061552015309155561526514698144761417212366124521271212709123831252812433122511263212694130961300512870127141252012416189281862918210183791801617519176261733717374NANANA16486NANANA15188NANANA
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment ▅▅▄▄▄▄▃▃▃▃▃▂▂▁▁▂▂▁▁▁▁▁▁▂▂▂▂▁▁██▇▇▇▆▆▅▆8800876185188506827981438072787778977658747971906907666167186886687366536731669565526697682271617057696568716751662510865106691037810424101429542949892589403NANANA8867NANANA7969NANANA
us-gaap:PropertyPlantAndEquipmentNet ▇█▇▇▇▆▆▆▇▆▅▆▆▁▁▁▁▁▁▁▁▂▁▂▂▂▁▁▁██▇█▇████79078038782578257626756374487432765976077219728672655705573458265836573057975738569959355872593559485905584257685791806379607831795578737977812880787970NANANA7619NANANA7219NANANA
us-gaap:LongTermInvestments ▂▂▂▂▂▂▃▂▂▂▃▄▄▆▆▇▇█▆▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▂▁▁790883874851867897971940913883138615451756294729973339355240413055243244229221130122119142154146273380389374378392451390302NANANA1132NANANA1073NANANA
 us-gaap:LongTermInvestments us-gaap:FairValueByMeasurementBasis,us-gaap:InvestmentType us-gaap:CarryingReportedAmountFairValueDisclosure,us-gaap:EquitySecurities▂▂▂▂▂▂▂▂▂▂▂▃▃▄▄▅▅▅▄▆█▁▁▁▁▁▁7418368308168328569348568307971300148217022906294632883500401430384898626121219595919393NANA213NANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermInvestments us-gaap:FairValueByMeasurementBasis,us-gaap:InvestmentType us-gaap:EstimateOfFairValueFairValueDisclosure,us-gaap:EquitySecurities▂▂▂▂▂▂▂▂▂▂▂▃▃▄▄▅▅▅▄▆█▁▁▁▁▁▁7418368308168328569348568307971300148217022906294632883500401430384898626121219595919393NANA213NANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermInvestments us-gaap:InvestmentType us-gaap:EquitySecurities▂▂▂▂▂▂▃▂▂▂▃▃▄▆▆▇▇█▆▁▁▁▁▁▁▁▁▁▁▁▁▁741836830816832856934856830797130014821702290629463288350040143038226227212195959193114126117213319329NA317296305234240NANANA153NANANA147NANANA
us-gaap:Goodwill ▇█████████▇▇▇▁▁▂▂▂▂▂▂▂▂▂▂▂▂▂▂▄▄▄▄▄▅▅▅▄22927231952304623329232092325423416238442422724020220662213221353768378129752977596389750989698551006710048975197819772972493579424157741570815356159031570516231167571662915930NANANA13200NANANA9987NANANA
 us-gaap:Goodwill us-gaap:StatementBusinessSegments abt:DiagnosticProducts▇▇▇▇▇▇▇███▁▁▁▁▁▁▁▁▁▁▁3600370037003700370037003700420041004100416417417452451451450450449443444NA444444NANANANANANA385384383383383NANANANANANANANANANANANANANA
 us-gaap:Goodwill us-gaap:StatementBusinessSegments abt:EstablishedPharmaceuticalProducts▁▄▄▅▄▄▅▅█▇▇▅▅▄▄▄▄▂▄██280030003000310030003000310031003300320032003100310030003000300030002900300033003300NA34003000NANANANANANA3000290031003000NANANANANANANANANANANANANANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill ▆▆▆▇▇▇▇▇██▇▇▇▁▁▁▁▁▂▂▂▂▂▁▁▁▂▁▂▃▃▃▃▃▄▄▄▄1626517025174651809118472189421947719951209432147318578186531940545394674531154585562584457855979619860945428561357355926564260578588895989839792998910793117391220712151NANANA6291NANANA5151NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:LiabilitiesCurrent ▄▄▄▃▃▃▅▃▃▂▂▁▁▁▂▂▂▃▂▃▃▄▄▃▃▃▄▄▃▅▇██▇▇▇██108081086310491906291139012127768951901089127935680366466660832186738393918687559185920610532108239853101869507113311091910406132801628517120167851548015413158391722517262NANANA13049NANANA11591NANANA
us-gaap:LongTermDebtCurrent ▃▃▃▁▁▁█▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁▂▃▃▃▃▁▁▄▅12641277125488740635065075085043334433323251552069892642642773081018101910271026342515332044NANANA211NANANA1040NANANA
us-gaap:OtherAccruedLiabilitiesCurrent ▃▃▃▃▃▃▃▃▃▃▂▂▂▁▁▁▂▂▂▂▂▁▁▂▂▂▃▃▃▇█▇███▆▆▆44084035411239614130378038073887414438113617335735062581271529313118304332943288338029432875324734013500378038934318678775427015768978547649632563966014NANANA4363NANANA4216NANANA
us-gaap:AccruedIncomeTaxesCurrent ▂▂▁▁▂▂▂▂▂▂▂▂▂▂▂▂▂▃▃▄▄▂▃▂▁▂▂▁▁▄▅▃▅▄▃▃██165226678327730523118821230918019218618824023226143048358953427048118115217522813814165570947775951446648712721307NANANA442NANANA805NANANA
us-gaap:DividendsPayableCurrent ▆▆▅▅▅▅▄▄▄▄▄▄▄▃▃▃▃▃▃▃▃▃▂▂▂▂▁▁▁▁███▇▇▇637635567566566563493492492489462461461391384383382383359358358362332331331341216218218221808800802754747747NA680NANANA620NANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship,us-gaap:HedgingDesignation abt:YenDenominatedLongTermDebt,us-gaap:NetInvestmentHedging,us-gaap:DesignatedAsHedgingInstrument█▁554546NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LongTermDebtNoncurrent ▅▅▅▆▆▆▆▆▆█▇▇▇▆▂▂▂▂▂▂▂▁▁▁▁▁▁▁▁▅▄▄▃▄▄▄▄▄1680416661176391898218845193591928419823211542721023310238102376420681597560165977587159535862593134083719340333873388340334103466180851205412004118611203913096126271253012523NANANA11266NANANA8713NANANA
us-gaap:MinorityInterest ██▇██▇▇▇▇▇▇▇▆▆▃▃▃▃▂▃▃▃▂▂▂▂▁▁▂▁▁▁▁▁▁▁▁▁2092132022082041981931972022011861861851791201201201151081181141131051029996919195929085898685909088NANANA43NANANA39NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:StockholdersEquity ▇▇██▇▇▇▇█▇███▁▁▁▁▁▁▃▂▂▂▃▃▄▃▂▂▅▅▃▄▃▃▅▃▂3021831088318173168630925305243070530577313993089732032316023136220538207762067520722212112111123008218742152622888236022339025171236962233622588267202701424486254532443924603263782462922388NANANA22855NANANA17479NANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▇▇██▇▇▇▇█▇███▁▁▁▁▁▁▂▂▂▂▃▃▄▃▂▂▅▅▃▄▃▃▅▃▂3042731301320193189431129307223089830774316013109832218317883154720717208962079520842213262121923126219882163922993237042348925267237872242722683268132710424572255432452624688264692472022476NANANA22898NANANA17518NANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:CommonStock▇█▇▆▄▄▃▂▁▁23731238532377123665234612351223428233172322323206NANANA13027NANANA12734NANANA12383NANANA12048NANANA11754NANANA9817NANANA8744NANANA8257NANANA7444NANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:RetainedEarnings██▇▅▄▃▂▂▁▁25786258472544025045246132456024144240802385623978NANANA25565NANANA25757NANANA22874NANANA21979NANANA24150NANANA20907NANANA18927NANANA17054NANANA13825NANANA
us-gaap:CommonStockValue ████████████▇▂▂▁▁▁▁▁▁▁▁▁▁▁2373123853237712366523461235122342823317232232320623118230122288613027129391283512744127341264112566124621238312207121261203212048NANANA11755NANANANANA900588428744NANANA8257NANANA7444NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ███▇▇▇▆▆▆▆▇▇▇█▇███▇▇▇▅▄▄▄▄▄▂▂▆▅▄▃▃▂▃▁▁2578625847254402504524613245602414424080238562397825320252022538725565251622588425654257572537525162247402287422335221372200521979216682031820062241502332622227213142090720052205091932318927NANANA17054NANANA13825NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▁▂▂▂▂▂▃▃▄▃▃▃▃▂▃▃▃▃▃▄▄▄▆▆▆▆▆▅▆▅▆▅▆▆▇██▇-9386-8465-7763-7365-7470-7586-7009-6913-5733-6062-6116-6250-6532-7263-6533-7223-6851-6658-7211-5004-5607-5053-2975-1952-1934-2012-2956-3226-2894-3593-2755-3543-1941-2597-860577182-1366NANANA854NANANA-1163NANANA
us-gaap:MinorityInterest ██▇██▇▇▇▇▇▇▇▆▆▃▃▃▃▂▃▃▃▂▂▂▂▁▁▂▁▁▁▁▁▁▁▁▁2092132022082041981931972022011861861851791201201201151081181141131051029996919195929085898685909088NANANA43NANANA39NANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities 715NANANA712NANANA1108NANANA574NANANA-93NANANA2NANANA336NANANA460NANANA2224NANANA2011NANANA1522NANANANANANANANA
us-gaap:NetCashProvidedByUsedInInvestingActivities -393NANANA-396NANANA-238NANANA-6154NANANA226NANANA-205NANANA-595NANANA-2108NANANA-4891NANANA-2301NANANA-7658NANANANANANANANA
us-gaap:NetCashProvidedByUsedInFinancingActivities -735NANANA-1142NANANA-6455NANANA-4399NANANA-1432NANANA-550NANANA-1152NANANA-4732NANANA165NANANA-684NANANA-520NANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities 715NANANA712NANANA1108NANANA574NANANA-93NANANA2NANANA336NANANA460NANANA2224NANANA2011NANANA1522NANANANANANANANA
us-gaap:NetIncomeLoss ▄▅▅▅▄▄▄▅▄▁▄▃▄▅▂▄▄▅▄▅█▅▄▄▄▄▅▄▄▅▇▇▆56410499601006672654563733418-828603283419798-32961531676758078422929055384663755899664765451053194317251242NANANANANANANANANANANANANANANANA
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings564NA9601006672NA563733418NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ProfitLoss 564NANANA672NANANA418NANANA419NANANANANANANANANANANANANANANANA1053194217241242161830319428631440890129110031538148012881438153610841322937
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet 369NANANA483NANANA182NANANA-101NANANA1261NANANA-230NANANA548NANANA489NANANA69NANANA217NANANA458NANANANANANANANA
us-gaap:IncreaseDecreaseInInventories 437NANANA286NANANA171NANANA162NANANA95NANANA128NANANA90NANANA131NANANA170NANANA-44NANANA49NANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities -393NANANA-396NANANA-238NANANA-6154NANANA226NANANA-205NANANA-595NANANA-2108NANANA-4891NANANA-2301NANANA-7658NANANANANANANANA
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment 360NANANA335NANANA275NANANA272NANANA243NANANA235NANANA255NANANA274NANANA453NANANA391NANANA245NANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities -735NANANA-1142NANANA-6455NANANA-4399NANANA-1432NANANA-550NANANA-1152NANANA-4732NANANA165NANANA-684NANANA-520NANANANANANANANA
us-gaap:RepaymentsOfLongTermDebt 1NANANA500NANANA5979NANANA2505NANANA7NANANA10NANANANANANANANANANANA54NANANA500NANANA1NANANANANANANANA
us-gaap:PaymentsOfDividendsCommonStock 638NANANA565NANANA491NANANA460NANANA385NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:PaymentsForRepurchaseOfCommonStock 236NANANA217NANANA128NANANA95NANANA519NANANA1346NANANA2192NANANA925NANANA987NANANA71NANANA861NANANANANANANANA
  2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
us-gaap:RepaymentsOfLongTermDebt 1NANANA500NANANA5979NANANA2505NANANA7NANANA10NANANANANANANANANANANA54NANANA500NANANA1NANANANANANANANA

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-06-302011-03-312010-12-312009-12-312008-12-31
Value23731238532377123665234612351223428233172322323206231182301222886130271293912835127441273412641125661246212383122071212612032120481175590058842874482577444
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets35.535.134.734.634.735.032.734.132.830.432.032.332.324.732.832.232.230.930.328.528.930.028.729.228.928.017.514.514.314.715.817.5

Shares Issued

Common Stock Shares Issued

us-gaap:CommonStockSharesIssued



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value1978197619761976197319711970196919691965196419621960170717061705170417021700169916981694169216911689168516821681167816751670165916521638162616251623161916121601
Percentage of CommonStockSharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Common Stock Shares Outstanding

us-gaap:StatementEquityComponents

us-gaap:CommonStockSharesOutstanding

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value19781976197619761973197119701969196919651707170216941685
Percentage of CommonStockSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStockCommon



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value209214208208209215214215216222234229186137
Percentage of CommonStockSharesOutstanding10.610.810.510.610.610.910.910.911.011.313.713.511.08.2

Common Stock Shares Authorized

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1780178417811776177117681765175417481735147614801483150515041515151915171547156615761586159415881589156815661558155415511561
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1768177117681763175917571753174317401727147614741477149514931504150815061532155115601568157615721573155815561551154515441547
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
Value0.320.590.540.570.380.370.320.420.24-0.480.340.160.240.54-0.220.410.210.510.390.521.520.590.360.30.240.380.620.30.350.661.221.090.791.030.191.240.560.930.580.830.650.990.950.830.930.990.70.860.61
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
Value0.310.590.530.560.380.370.320.410.23-0.480.340.160.240.53-0.220.410.210.510.380.521.510.590.360.30.240.370.610.30.340.661.211.080.781.020.191.230.550.920.570.830.640.980.950.830.920.980.690.850.6
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Basic Share

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value0.310.590.540.570.380.370.310.410.23-0.50.320.150.220.51-0.240.40.040.460.40.520.350.420.290.30.220.380.50.30.35-0.330.210.260.22
Percentage of IncomeLossFromContinuingOperationsPerBasicShare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Diluted Share

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value0.30.590.530.560.380.370.310.40.23-0.50.320.150.220.51-0.240.40.040.460.390.520.350.410.290.30.220.370.490.30.34-0.330.210.260.22
Percentage of IncomeLossFromContinuingOperationsPerDilutedShare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
Value772683148076797975357765765677677390758968296637633553335302533348855188515051704897535651045551524456555369544653771083697739807945610377981696169040996786748826769887907761749467187950749773146765
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems

us-gaap:OperatingSegments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value7711739573616954712472816960644262855853468847284362457845934357446849014637419848084762
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax99.891.692.392.393.193.794.294.394.792.488.488.789.388.988.889.087.588.388.478.288.388.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax99.891.692.392.393.193.794.294.394.792.488.488.789.388.988.889.087.588.388.478.288.388.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, abt:DiagnosticProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value1826190919051841182418731837127912731158121312261118115611771093118011891117112511351088
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax23.623.623.924.423.824.124.918.719.218.322.923.022.922.422.822.323.121.421.321.020.820.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax23.623.623.924.423.824.124.918.719.218.322.923.022.922.422.822.323.121.421.321.020.820.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:DiagnosticProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingSegments, abt:EstablishedPharmaceuticalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value1044121211089921159112910441171102195010129808889619778977711216115169112181233
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.515.013.913.215.114.514.117.115.415.019.118.418.218.718.918.315.121.921.912.922.422.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.515.013.913.215.114.514.117.115.415.019.118.418.218.718.918.315.121.921.912.922.422.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:EstablishedPharmaceuticalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingSegments, abt:MedicalDevices



Period End2020-03-312019-03-31
Value29372895
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax38.038.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax38.038.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:MedicalDevices100.0100.0

us-gaap:OperatingSegments, abt:NutritionalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value1904187418751792183818581756176817311642175517401671178917171669178717311631163517041699
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.623.223.523.824.023.923.825.926.125.933.132.634.234.733.234.135.031.231.130.531.331.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.623.223.523.824.023.923.825.926.125.933.132.634.234.733.234.135.031.231.130.531.331.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:NutritionalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

abt:DiagnosticProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value1826190919051841182418731837127912731158
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax23.623.623.924.423.824.124.918.719.218.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax23.623.623.924.423.824.124.918.719.218.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:DiagnosticProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:EstablishedPharmaceuticalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value10441212110899211591129104411711021950
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.515.013.913.215.114.514.117.115.415.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.515.013.913.215.114.514.117.115.415.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:EstablishedPharmaceuticalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:MedicalDevices



Period End2020-03-312019-03-31
Value29372895
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax38.038.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax38.038.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices100.0100.0

abt:NutritionalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value1904187418751792183818581756176817311642
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.623.223.523.824.023.923.825.926.125.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.623.223.523.824.023.923.825.926.125.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:NutritionalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllOtherSegments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value15681618581532486430387352482614605523572577540636650607627638616
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.28.47.77.76.96.35.85.75.37.611.611.310.711.111.211.012.511.711.611.711.711.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.28.47.77.76.96.35.85.75.37.611.611.310.711.111.211.012.511.711.611.711.711.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AllOtherSegments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments, us-gaap:Subsegments

abt:DiagnosticProducts, abt:CoreLaboratory



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value98911771169106110861128101910331020911
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.814.614.714.114.214.513.815.115.414.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.814.614.714.114.214.513.815.115.414.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:DiagnosticProducts abt:CoreLaboratory100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:DiagnosticProducts, abt:Molecular



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value139111107108121122118115114112
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.81.41.31.41.61.61.61.71.71.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.81.41.31.41.61.61.61.71.71.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:DiagnosticProducts abt:Molecular100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:DiagnosticProducts, abt:PointOfCare



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value138144145135136139141131139135
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.81.81.81.81.81.81.91.92.12.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.81.81.81.81.81.81.91.92.12.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:DiagnosticProducts abt:PointOfCare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:DiagnosticProducts, abt:RapidDiagnostics



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value560477484537481484559
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.25.96.17.16.36.27.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.25.96.17.16.36.27.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:DiagnosticProducts abt:RapidDiagnostics100.0100.0100.0100.0100.0100.0100.0

abt:EstablishedPharmaceuticalProducts, abt:KeyEmergingMarkets



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value813891853752866866793885798730
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.511.010.710.011.311.110.713.012.011.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.511.010.710.011.311.110.713.012.011.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:EstablishedPharmaceuticalProducts abt:KeyEmergingMarkets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:EstablishedPharmaceuticalProducts, abt:Other



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value231321255240293263251286223220
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.04.03.23.23.83.43.44.23.43.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.04.03.23.23.83.43.44.23.43.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:EstablishedPharmaceuticalProducts abt:Other100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:MedicalDevices, abt:DiabetesCare



Period End2020-03-312019-03-31
Value752566
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.77.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.77.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:DiabetesCare100.0100.0

abt:MedicalDevices, abt:Electrophysiology



Period End2020-03-312019-03-31
Value388405
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.05.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.05.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:Electrophysiology100.0100.0

abt:MedicalDevices, abt:HeartFailure



Period End2020-03-312019-03-31
Value203184
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.62.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:HeartFailure100.0100.0

abt:MedicalDevices, abt:Neuromodulation



Period End2020-03-312019-03-31
Value177193
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.32.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.32.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:Neuromodulation100.0100.0

abt:MedicalDevices, abt:RhythmManagement



Period End2020-03-312019-03-31
Value474514
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.16.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.16.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:RhythmManagement100.0100.0

abt:MedicalDevices, abt:StructuralHeart



Period End2020-03-312019-03-31
Value318324
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.14.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.14.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:StructuralHeart100.0100.0

abt:MedicalDevices, abt:VascularProducts



Period End2020-03-312019-03-31
Value625709
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.19.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.19.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:MedicalDevices abt:VascularProducts100.0100.0

abt:NutritionalProducts, abt:AdultNutritionals



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value815830824763799807762793744715
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.510.310.310.110.410.410.311.611.211.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.510.310.310.110.410.410.311.611.211.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:NutritionalProducts abt:AdultNutritionals100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:NutritionalProducts, abt:PediatricNutritionals



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value108910441051102910391051994975987927
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax14.112.913.213.713.613.513.514.314.914.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax14.112.913.213.713.613.513.514.314.914.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax abt:NutritionalProducts abt:PediatricNutritionals100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical

country:US



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value2856283428502754270727022675231323602324
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax37.035.135.736.535.434.836.233.935.636.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax37.035.135.736.535.434.836.233.935.636.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value4870524251294781494950654715451642774011
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax63.064.964.363.564.665.263.866.164.463.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax63.064.964.363.564.665.263.866.164.463.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments

country:US, abt:DiagnosticProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value803702695724666652700369385
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.48.78.79.68.78.49.55.45.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.48.78.79.68.78.49.55.45.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:DiagnosticProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, abt:MedicalDevices



Period End2020-03-312019-03-31
Value12331275
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.016.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.016.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices100.0100.0

country:US, abt:NutritionalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value812788786747774781758759773
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.59.89.99.910.110.110.311.111.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.59.89.99.910.110.110.311.111.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:NutritionalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:AllOtherSegments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value8184167160133122949292
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.12.32.12.11.71.61.31.31.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.12.32.12.11.71.61.31.31.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US us-gaap:AllOtherSegments100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:DiagnosticProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value1023120712101117115812211137910888
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.214.915.214.815.115.715.413.313.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.214.915.214.815.115.715.413.313.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:DiagnosticProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:EstablishedPharmaceuticalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value10441212110899211591129104411711021
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.515.013.913.215.114.514.117.115.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.515.013.913.215.114.514.117.115.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:EstablishedPharmaceuticalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:MedicalDevices



Period End2020-03-312019-03-31
Value17041620
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax22.121.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax22.121.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices100.0100.0

us-gaap:NonUs, abt:NutritionalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value1092108610891045106410779981009958
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax14.113.413.613.913.913.913.514.814.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax14.113.413.613.913.913.913.514.814.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:NutritionalProducts100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, us-gaap:AllOtherSegments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value7497451421399364336295260
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.16.25.75.65.24.74.54.33.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.16.25.75.65.24.74.54.33.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs us-gaap:AllOtherSegments100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments, us-gaap:Subsegments

country:US, abt:DiagnosticProducts, abt:CoreLaboratory



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value267272272249249248228230232
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.43.43.33.33.23.13.43.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.53.43.43.33.33.23.13.43.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:DiagnosticProducts abt:CoreLaboratory100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, abt:DiagnosticProducts, abt:Molecular



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value653538403738393741
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.40.50.50.50.50.50.50.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.40.50.50.50.50.50.50.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:DiagnosticProducts abt:Molecular100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, abt:DiagnosticProducts, abt:PointOfCare



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value103112113109106108110102112
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.41.41.41.41.41.51.51.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.41.41.41.41.41.51.51.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:DiagnosticProducts abt:PointOfCare100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, abt:DiagnosticProducts, abt:RapidDiagnostics



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value368283272326274258323
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.83.53.44.33.63.34.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.83.53.44.33.63.34.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:DiagnosticProducts abt:RapidDiagnostics100.0100.0100.0100.0100.0100.0100.0

country:US, abt:MedicalDevices, abt:DiabetesCare



Period End2020-03-312019-03-31
Value186152
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.42.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.42.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices abt:DiabetesCare100.0100.0

country:US, abt:MedicalDevices, abt:Electrophysiology



Period End2020-03-312019-03-31
Value164174
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.12.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.12.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices abt:Electrophysiology100.0100.0

country:US, abt:MedicalDevices, abt:HeartFailure



Period End2020-03-312019-03-31
Value152143
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.01.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.01.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices abt:HeartFailure100.0100.0

country:US, abt:MedicalDevices, abt:Neuromodulation



Period End2020-03-312019-03-31
Value137152
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.82.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.82.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices abt:Neuromodulation100.0100.0

country:US, abt:MedicalDevices, abt:RhythmManagement



Period End2020-03-312019-03-31
Value228252
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.03.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.03.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices abt:RhythmManagement100.0100.0

country:US, abt:MedicalDevices, abt:VascularProducts



Period End2020-03-312019-03-31
Value230266
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.03.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.03.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:MedicalDevices abt:VascularProducts100.0100.0

country:US, abt:NutritionalProducts, abt:AdultNutritionals



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value294310311294315312310323314
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.83.83.93.94.14.04.24.74.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.83.83.93.94.14.04.24.74.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:NutritionalProducts abt:AdultNutritionals100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, abt:NutritionalProducts, abt:PediatricNutritionals



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value518478475453459469448436459
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.75.96.06.06.06.06.16.46.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.75.96.06.06.06.06.16.46.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US abt:NutritionalProducts abt:PediatricNutritionals100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:DiagnosticProducts, abt:CoreLaboratory



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value722905897812837880791803788
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.311.211.210.810.911.310.711.811.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.311.211.210.810.911.310.711.811.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:DiagnosticProducts abt:CoreLaboratory100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:DiagnosticProducts, abt:Molecular



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value747669688484797873
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.90.90.91.11.11.11.11.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.90.90.91.11.11.11.11.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:DiagnosticProducts abt:Molecular100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:DiagnosticProducts, abt:PointOfCare



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value353232263031312927
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.40.40.30.40.40.40.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.40.40.30.40.40.40.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:DiagnosticProducts abt:PointOfCare100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:DiagnosticProducts, abt:RapidDiagnostics



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value192194212211207226236
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.52.42.72.82.72.93.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.52.42.72.82.72.93.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:DiagnosticProducts abt:RapidDiagnostics100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:EstablishedPharmaceuticalProducts, abt:KeyEmergingMarkets



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value813891853752866866793885798
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.511.010.710.011.311.110.713.012.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.511.010.710.011.311.110.713.012.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:EstablishedPharmaceuticalProducts abt:KeyEmergingMarkets100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:EstablishedPharmaceuticalProducts, abt:Other



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value231321255240293263251286223
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.04.03.23.23.83.43.44.23.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.04.03.23.23.83.43.44.23.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:EstablishedPharmaceuticalProducts abt:Other100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:DiabetesCare



Period End2020-03-312019-03-31
Value566414
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.35.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.35.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:DiabetesCare100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:Electrophysiology



Period End2020-03-312019-03-31
Value224231
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.93.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.93.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:Electrophysiology100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:HeartFailure



Period End2020-03-312019-03-31
Value5141
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:HeartFailure100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:Neuromodulation



Period End2020-03-312019-03-31
Value4041
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:Neuromodulation100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:RhythmManagement



Period End2020-03-312019-03-31
Value246262
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.23.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.23.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:RhythmManagement100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:StructuralHeart



Period End2020-03-312019-03-31
Value182188
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.42.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.42.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:StructuralHeart100.0100.0

us-gaap:NonUs, abt:MedicalDevices, abt:VascularProducts



Period End2020-03-312019-03-31
Value395443
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.15.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.15.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:MedicalDevices abt:VascularProducts100.0100.0

us-gaap:NonUs, abt:NutritionalProducts, abt:AdultNutritionals



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value521520513469484495452470430
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.76.46.46.26.36.46.16.96.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.76.46.46.26.36.46.16.96.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:NutritionalProducts abt:AdultNutritionals100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NonUs, abt:NutritionalProducts, abt:PediatricNutritionals



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value571566576576580582546539528
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.47.07.27.67.67.57.47.98.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.47.07.27.67.67.57.47.98.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NonUs abt:NutritionalProducts abt:PediatricNutritionals100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenues

Sales Revenue Net

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value328133583279316031663282306728763189
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax42.541.641.141.941.442.341.542.148.0

Cost Of Goods Sold

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value2548244024342478237724662542209921322424162817371698166617271737160317881762173417141785292129443000423827622850267327432162
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax33.030.230.532.931.031.734.430.732.138.330.732.634.832.333.435.531.432.233.632.331.533.229.930.031.743.228.731.530.831.128.1

Interest Expense

us-gaap:InterestExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value13916716817120321022721821422611710358414437353939394040152127126124134145149134118
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.82.12.12.32.72.73.13.23.23.62.21.91.20.80.90.80.70.70.70.70.70.81.61.31.31.31.41.61.71.51.5

Gross Profit

Costs And Expenses

us-gaap:CostsAndExpenses



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value6968687867736796666168856782601962106537440545174361443744414287437347904793473848184763778477027880922178427739749372206227
Percentage of CostsAndExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax90.285.284.990.287.088.691.888.193.6103.283.184.789.386.285.987.585.786.391.488.388.588.679.678.583.393.981.685.686.481.880.9

Research And Development Expense

us-gaap:ResearchAndDevelopmentExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value578596577672574575589
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.57.47.28.97.57.48.0

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value2548244024342478237724662542209921322424162817371698166617271737160317881762173417141785292129443000423827622850267327432162
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax33.030.230.532.931.031.734.430.732.138.330.732.634.832.333.435.531.432.233.632.331.533.229.930.031.743.228.731.530.831.128.1

Operating Income Loss

us-gaap:OperatingIncomeLoss



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value75811981206739995882608810427-20289781652471372961073176145163062761419892104157559417731301118116051470
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.814.815.19.813.011.48.211.96.4-3.216.915.310.713.814.112.514.313.78.611.711.511.420.421.516.76.118.414.413.618.219.1

us-gaap:ConsolidationItems

us-gaap:OperatingSegments



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-30
Value184818921871166718971882169917091599149111991138100411821145107711191044
Percentage of OperatingIncomeLoss243.8157.9155.1225.6190.7213.4279.4211.0374.5-738.1133.7139.5191.6165.8157.1176.6153.1137.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax23.923.423.422.124.824.223.025.024.123.522.621.320.623.022.122.021.918.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments24.025.625.424.026.625.824.426.525.425.525.624.123.025.824.924.725.021.3

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, abt:DiagnosticProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-30
Value405456466434443489443353338284301288267307304276310279
Percentage of OperatingIncomeLoss53.438.138.658.744.555.472.943.679.2-140.633.635.351.043.141.745.242.436.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.25.65.85.85.86.36.05.25.14.55.75.45.56.05.95.66.15.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:DiagnosticProducts22.223.924.523.624.326.124.127.626.624.524.823.523.926.625.825.326.323.5

us-gaap:OperatingSegments, abt:EstablishedPharmaceuticalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-30
Value181281214159289208167271180140211192148177172167160160
Percentage of OperatingIncomeLoss23.923.517.721.529.023.627.533.542.2-69.323.523.528.224.823.627.421.921.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.33.52.72.13.82.72.34.02.72.24.03.63.03.43.33.43.12.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:EstablishedPharmaceuticalProducts17.323.219.316.024.918.416.023.117.614.720.819.616.718.417.618.620.813.2

us-gaap:OperatingSegments, abt:MedicalDevices



Period End2020-03-312019-03-31
Value803847
Percentage of OperatingIncomeLoss105.9114.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.411.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:MedicalDevices27.329.3

us-gaap:OperatingSegments, abt:NutritionalProducts



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-30
Value459414447380435424365403392351438368342459389350369302
Percentage of OperatingIncomeLoss60.634.637.151.443.748.160.049.891.8-173.848.845.165.364.453.457.450.539.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.95.15.65.05.75.54.95.95.95.58.36.97.08.97.57.17.25.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments abt:NutritionalProducts24.122.123.821.223.722.820.822.822.621.425.021.120.525.722.721.020.617.4

Interest Expense

us-gaap:InterestExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value13916716817120321022721821422611710358414437353939394040152127126124134145149134118
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.82.12.12.32.72.73.13.23.23.62.21.91.20.80.90.80.70.70.70.70.70.81.61.31.31.31.41.61.71.51.5

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value1553847-187833-8391126-972-8-19327953-3-3267-510-87155-140-4810
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.70.50.6-0.21.00.4-0.10.617.8-18.3-0.2-0.40.15.40.10.1-0.1-0.10.50.1-0.10.1-0.10.80.10.1-1.6-0.10.10.1

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-31
Value63311031102632718777431626295736-179715271498665371873742362860055418722003151350116741068
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.213.713.88.49.410.05.89.24.411.6-3.413.40.013.919.113.314.113.38.111.711.010.319.220.416.05.117.411.8

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value54410499601006672655552718409-864561270386875-35759956695596786529634440460339589772476544-522338410351
Percentage of IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.012.611.912.68.98.47.29.25.5-11.48.24.16.116.4-6.711.21.113.411.615.210.811.88.68.36.510.414.48.710.1-4.83.54.23.7

Income Loss From Continuing Operations Before Income Taxes Domestic

Income Loss From Continuing Operations Before Income Taxes Foreign

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value8914396-4016659226525350178116-5411820012427827784-1441249-70278270198-268204173267319
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.81.2-0.52.20.80.31.00.45.53.42.2-1.12.33.92.55.45.01.6-2.72.30.2-0.72.82.92.0-2.82.32.03.04.1

Income Taxes Paid Net

Profit Loss

us-gaap:ProfitLoss



Period End2020-03-312019-03-312018-03-312017-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
Value5646724184191053194217241242161830319428631440890129110031538148012881438153610841322937
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.38.95.76.69.719.917.613.115.63.120.29.614.510.314.613.017.519.117.221.419.314.518.113.9

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value-3575621111788467-4477427375651001361243123-162713871611-1135233924132038-362-827
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-4.67.013.910.56.1-5.810.010.88.515.86.84.62.5-31.626.832.9-11.624.326.723.5-4.1-10.7

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value56410499601006672654563733418-828603283419798-32961531676758078422929055384663755899664765451053194317251242
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.312.611.912.68.98.47.49.45.7-10.98.84.36.615.0-6.211.56.514.811.315.246.816.910.58.47.210.418.08.710.19.719.917.613.1

us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value5649601006672563733418
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.311.912.68.97.49.45.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.0

Net Income Loss Available To Common Stockholders Basic

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-30
Value5619541000668560730415601281417-32961231557778022815364633739654765441942172412423031942863890
Percentage of NetIncomeLossAvailableToCommonStockholdersBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.311.812.58.97.39.45.68.84.26.6-6.211.56.411.215.146.610.58.37.118.08.710.119.917.613.13.120.29.610.3

Assets

us-gaap:Assets



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value66777678876853968427676106717371637684157090876250722487115170887526663949739831396374124741725441254309541275425144147541662429534413242903426866723463257618596241560276596286200461651594625241642419
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value66777678876853968427676106717371637684157090876250722487115170887526663949739831396374124741725441254309541275425144147541662429534413242903426866723463257618596241560276596286200461651594625241642419
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value30218310883181731686309253052430705305773139930897320323160231362205382077620675207222121121111230082187421526228882360223390251712369622336225882672027014244862545324439246032637824629223882285517479
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets45.345.846.446.345.745.442.944.744.340.544.344.444.239.052.651.952.351.450.652.150.852.253.856.956.158.653.752.152.939.742.739.640.840.541.342.539.937.743.641.2

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value-3483-3540-2646-2677-2703-2726-2415-2437-2498-2521-2192-2215-2244-2284-1972-1987-1940-1958-2229
Percentage of StockholdersEquity-11.5-11.4-8.3-8.4-8.7-8.9-7.9-8.0-8.0-8.2-6.8-7.0-7.2-11.1-9.5-9.6-9.4-9.2-10.4
Percentage of Assets-5.2-5.2-3.9-3.9-4.0-4.1-3.4-3.6-3.5-3.3-3.0-3.1-3.2-4.3-5.0-5.0-4.9-4.7-5.4
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value165-160112352372-116-84-90-52-1549
Percentage of StockholdersEquity0.5-0.00.20.00.10.20.10.0-0.4-0.3-0.3-0.2-0.00.2
Percentage of Assets0.2-0.00.10.00.00.10.10.0-0.2-0.1-0.1-0.1-0.00.1
Percentage of Assets us-gaap:AccumulatedGainLossNetCashFlowHedgeParent0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value-6068-4924-5177-4699-4790-4912-4631-4478-3119-3452-3711-3996-4284-4959-4423-4512-4408-4829-2924
Percentage of StockholdersEquity-20.1-15.8-16.3-14.8-15.5-16.1-15.1-14.6-9.9-11.2-11.6-12.6-13.7-24.1-21.3-21.8-21.3-22.8-13.6
Percentage of Assets-9.1-7.3-7.6-6.9-7.1-7.3-6.5-6.5-4.4-4.5-5.1-5.6-6.0-9.4-11.2-11.3-11.1-11.7-7.1
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Assets Current

us-gaap:AssetsCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value15498156671611915195144091463218196141221496420147213771998319329267761297812988124061415515894211311998515261164641825817931192471974819831190963132227264262572560223768230942413223647223172331317042
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets23.223.123.522.221.321.825.420.621.126.429.628.127.350.832.932.631.334.338.147.946.437.038.744.043.044.844.746.244.746.643.142.441.039.438.738.938.437.544.540.2

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312008-12-312007-12-31
Value33773860409131373022384473693065385794071101296758706186202500257833345001313240483226406336133570206034752882557243731080279967052434568125049407727403648381843211566880941122456
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.15.76.04.64.55.710.34.55.412.315.213.612.335.46.36.58.412.17.59.27.59.88.58.64.98.16.513.010.216.112.611.47.011.38.56.64.46.10.00.00.016.89.70.0

Short Term Investments

us-gaap:ShortTermInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value29128024423923924218119918520318716015415520071860623112430077129662339712643492498746235723382141444371350739495180128429274816376218031122967
Percentage of ShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.40.40.40.30.40.40.30.30.30.30.30.20.20.35.14.71.62.77.216.215.41.03.08.412.010.813.08.99.76.55.56.48.32.14.97.86.13.02.12.3

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value5292542554505548534551825271519253565249480046334510324833203567343034183460355334813586361840563883398638823938391776126948676776597683704370387160718465415465
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.98.08.08.17.97.77.47.67.66.96.66.56.46.28.49.08.78.38.38.18.18.78.59.89.39.38.89.29.211.311.010.912.312.711.811.411.612.112.512.9

Inventory Net

us-gaap:InventoryNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value4568431643924352408537963781371438263601348336033995243426132813278625992633273526232643269628232775269328042725271037923814351835493284326934753400318832642775
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.86.46.46.46.05.75.35.45.44.74.85.15.64.66.67.17.06.36.36.26.16.46.36.86.76.36.46.46.35.66.05.75.75.45.55.65.55.46.26.5

Inventory Finished Goods

Other Assets Current

Land

Machinery And Equipment Gross

Noncurrent Assets

Property Plant And Equipment Gross

us-gaap:PropertyPlantAndEquipmentGross



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value16707167991634316331159051570615520153091555615265146981447614172123661245212712127091238312528124331225112632126941309613005128701271412520124161892818629182101837918016175191762617337173741648615188
Percentage of PropertyPlantAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets25.024.723.823.923.523.421.722.421.920.020.320.320.023.531.531.932.130.030.028.228.430.629.931.631.230.028.829.229.128.229.529.429.429.929.428.428.129.231.535.8

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value880087618518850682798143807278777897765874797190690766616718688668736653673166956552669768227161705769656871675166251086510669103781042410142954294989258940388677969
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets13.212.912.412.412.212.111.311.511.110.010.410.19.712.617.017.317.316.116.115.215.216.216.017.316.916.215.615.715.516.216.916.816.716.816.015.315.015.816.918.8

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value7907803878257825762675637448743276597607721972867265570557345826583657305797573856995935587259355948590558425768579180637960783179557873797781288078797076197219
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets11.811.811.411.411.311.310.410.910.810.010.010.210.210.814.514.614.713.913.913.013.214.413.814.314.313.713.213.413.612.012.612.712.713.113.413.113.113.414.517.0

Long Term Investments

us-gaap:LongTermInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value79088387485186789797194091388313861545175629472997333935524041305524324422922113012211914215414627338038937437839245139030211321073
Percentage of LongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.21.31.31.21.31.31.41.41.31.21.92.22.55.67.68.49.09.87.30.60.60.60.50.30.30.30.30.40.30.40.60.60.60.60.70.70.60.52.22.5

us-gaap:FairValueByMeasurementBasis, us-gaap:InvestmentType

us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:EquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value7418368308168328569348568307971300148217022906294632883500401430384898626121219595919393213
Percentage of LongTermInvestments93.894.795.095.996.095.496.291.190.990.393.895.996.998.698.398.598.599.399.42015.62566.092.688.273.174.678.265.377.9
Percentage of Assets1.11.21.21.21.21.31.31.31.21.01.82.12.45.57.58.38.89.77.311.114.50.50.50.20.20.20.20.3
Percentage of Assets us-gaap:CarryingReportedAmountFairValueDisclosure us-gaap:EquitySecurities0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CarryingReportedAmountFairValueDisclosure, us-gaap:OtherAggregatedInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value49474435354137848386866354415151522717171717263531262661
Percentage of LongTermInvestments6.25.35.04.14.04.63.88.99.19.76.24.13.11.41.71.51.50.70.67.07.07.411.826.925.421.818.222.3
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.10.10.10.10.10.1
Percentage of Assets us-gaap:CarryingReportedAmountFairValueDisclosure us-gaap:OtherAggregatedInvestments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:EquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value7418368308168328569348568307971300148217022906294632883500401430384898626121219595919393213
Percentage of LongTermInvestments93.894.795.095.996.095.496.291.190.990.393.895.996.998.698.398.598.599.399.42015.62566.092.688.273.174.678.265.377.9
Percentage of Assets1.11.21.21.21.21.31.31.31.21.01.82.12.45.57.58.38.89.77.311.114.50.50.50.20.20.20.20.3
Percentage of Assets us-gaap:EstimateOfFairValueFairValueDisclosure us-gaap:EquitySecurities0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:EstimateOfFairValueFairValueDisclosure, us-gaap:OtherAggregatedInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value49474435354137848386866355425554543017171717183126242456
Percentage of LongTermInvestments6.25.35.04.14.04.63.88.99.19.76.24.13.11.41.81.61.50.70.67.07.07.48.123.821.320.216.820.5
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.10.10.10.10.1
Percentage of Assets us-gaap:EstimateOfFairValueFairValueDisclosure us-gaap:OtherAggregatedInvestments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:InvestmentType

us-gaap:EquitySecurities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value741836830816832856934856830797130014821702290629463288350040143038226227212195959193114126117213319329317296305234240153147
Percentage of LongTermInvestments93.894.795.095.996.095.496.291.190.990.393.895.996.998.698.398.598.599.399.493.093.092.688.273.174.678.280.081.780.177.983.984.483.875.467.560.079.513.513.7
Percentage of Assets1.11.21.21.21.21.31.31.31.21.01.82.12.45.57.58.38.89.77.30.50.50.50.50.20.20.20.30.30.30.30.50.50.50.50.50.40.40.30.3
Percentage of Assets us-gaap:EquitySecurities0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:OtherInvestments



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312010-12-312009-12-31
Value49474435354137848386866354415151522717171717263531262928296161616162100
Percentage of LongTermInvestments6.25.35.04.14.04.63.88.99.19.76.24.13.11.41.71.51.50.70.67.07.07.411.826.925.421.820.318.219.922.316.015.616.120.58.8
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.10.10.10.10.10.10.10.10.10.10.10.10.2
Percentage of Assets us-gaap:OtherInvestments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Goodwill

us-gaap:Goodwill



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value22927231952304623329232092325423416238442422724020220662213221353768378129752977596389750989698551006710048975197819772972493579424157741570815356159031570516231167571662915930132009987
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets34.334.233.634.134.334.632.734.934.231.530.531.130.114.619.824.524.723.423.422.422.924.423.623.523.522.822.021.822.123.524.824.825.526.127.227.027.026.825.223.5

us-gaap:StatementBusinessSegments

abt:DiagnosticProducts



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-09-302014-06-302012-09-302012-06-302012-03-312011-12-312011-09-30
Value3600370037003700370037003700420041004100416417417452451451450450449443444444444385384383383383
Percentage of Goodwill15.716.016.115.915.915.915.817.616.917.11.91.92.05.95.84.64.64.74.64.54.54.44.62.52.52.42.42.4
Percentage of Assets5.45.55.45.45.55.55.26.15.85.40.60.60.60.91.11.11.11.11.11.01.01.01.10.60.60.60.60.6
Percentage of Assets abt:DiagnosticProducts0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.011.20.0

abt:EstablishedPharmaceuticalProducts



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-09-302014-06-302012-09-302012-06-302012-03-312011-12-31
Value280030003000310030003000310031003300320032003100310030003000300030002900300033003300340030003000290031003000
Percentage of Goodwill12.212.913.013.312.912.913.213.013.613.314.514.014.539.038.430.830.730.130.833.333.533.830.819.118.919.519.1
Percentage of Assets4.24.44.44.54.44.54.34.54.74.24.44.44.45.77.67.57.67.07.27.57.78.07.24.74.75.05.0
Percentage of Assets abt:EstablishedPharmaceuticalProducts0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.042.9

abt:NutritionalProducts



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-09-302014-06-302012-09-302012-06-302012-03-312011-12-312011-09-30
Value286286286286286286286286286286286286286286286286286286286286286286286209207207207208
Percentage of Goodwill1.21.21.21.21.21.21.21.21.21.21.31.31.33.73.72.92.93.02.92.92.92.82.91.31.31.31.31.3
Percentage of Assets0.40.40.40.40.40.40.40.40.40.40.40.40.40.50.70.70.70.70.70.60.70.70.70.30.30.30.30.3
Percentage of Assets abt:NutritionalProducts0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.06.40.0

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value162651702517465180911847218942194771995120943214731857818653194054539467453115458556258445785597961986094542856135735592656426057858889598983979299891079311739122071215162915151
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets24.425.125.526.427.328.227.229.229.528.225.726.227.48.611.813.313.813.514.013.113.915.014.313.113.513.413.413.214.212.814.214.515.716.618.118.919.820.412.012.1

Intangible Assets Net Including Goodwill

Deferred Tax Assets Liabilities Net

Other Assets Noncurrent

Liabilities Current

us-gaap:LiabilitiesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value1080810863104919062911390121277689519010891279356803664666608321867383939186875591859206105321082398531018695071133110919104061328016285171201678515480154131583917225172621304911591
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets16.216.015.313.213.513.417.813.112.711.711.09.69.412.621.121.821.222.321.020.821.425.525.523.824.422.125.725.524.419.825.727.726.925.725.925.527.929.024.927.3

Long Term Debt Current

us-gaap:LongTermDebtCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value126412771254887406350650750850433344333232515520698926426427730810181019102710263425153320442111040
Percentage of LongTermDebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.91.91.80.00.00.05.70.70.70.70.70.00.00.00.00.00.00.00.10.10.10.10.50.00.00.00.60.60.70.51.61.61.61.70.10.02.53.40.42.5

Other Accrued Liabilities Current

us-gaap:OtherAccruedLiabilitiesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value4408403541123961413037803807388741443811361733573506258127152931311830433294328833802943287532473401350037803893431867877542701576897854764963256396601443634216
Percentage of OtherAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.65.96.05.86.15.65.35.75.85.05.04.74.94.96.97.47.97.47.97.57.87.16.87.88.28.18.69.110.110.111.911.312.313.012.810.210.410.18.39.9

Accrued Income Taxes Current

us-gaap:AccruedIncomeTaxesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value165226678327730523118821230918019218618824023226143048358953427048118115217522813814165570947775951446648712721307442805
Percentage of AccruedIncomeTaxesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.30.10.10.40.50.30.30.30.40.20.30.30.40.60.60.71.01.21.31.20.71.10.40.40.40.50.30.31.01.10.81.20.90.80.82.12.20.81.9

Dividends Payable Current

us-gaap:DividendsPayableCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302010-12-312009-12-31
Value637635567566566563493492492489462461461391384383382383359358358362332331331341216218218221808800802754747747680620
Percentage of DividendsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.00.90.80.80.80.80.70.70.70.60.60.60.70.71.01.01.00.90.90.80.80.90.80.80.80.80.50.50.50.31.31.31.31.31.31.21.11.2

Long Term Debt

us-gaap:DebtInstrument, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:LongTermDebt

abt:YenDenominatedLongTermDebt, us-gaap:NetInvestmentHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-31
Value554546
Percentage of LongTermDebt100.0100.0
Percentage of Assets0.80.8
Percentage of Assets abt:YenDenominatedLongTermDebt us-gaap:NetInvestmentHedging us-gaap:DesignatedAsHedgingInstrument0.00.0

Long Term Debt Noncurrent

us-gaap:LongTermDebtNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value1680416661176391898218845193591928419823211542721023310238102376420681597560165977587159535862593134083719340333873388340334103466180851205412004118611203913096126271253012523112668713
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets25.224.525.727.727.928.826.929.029.835.732.333.533.539.315.115.115.114.214.313.313.88.38.78.28.17.97.77.98.126.919.119.419.020.022.020.420.321.121.520.5

Deferred Tax Liabilities Noncurrent

Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value20921320220820419819319720220118618618517912012012011510811811411310510299969191959290858986859090884339
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.20.20.20.20.20.20.20.10.10.10.10.10.10.10.10.10.10.1

Other Liabilities Noncurrent

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value30218310883181731686309253052430705305773139930897320323160231362205382077620675207222121121111230082187421526228882360223390251712369622336225882672027014244862545324439246032637824629223882285517479
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets45.345.846.446.345.745.442.944.744.340.544.344.444.239.052.651.952.351.450.652.150.852.253.856.956.158.653.752.152.939.742.739.640.840.541.342.539.937.743.641.2

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value-3483-3540-2646-2677-2703-2726-2415-2437-2498-2521-2192-2215-2244-2284-1972-1987-1940-1958-2229
Percentage of StockholdersEquity-11.5-11.4-8.3-8.4-8.7-8.9-7.9-8.0-8.0-8.2-6.8-7.0-7.2-11.1-9.5-9.6-9.4-9.2-10.4
Percentage of Assets-5.2-5.2-3.9-3.9-4.0-4.1-3.4-3.6-3.5-3.3-3.0-3.1-3.2-4.3-5.0-5.0-4.9-4.7-5.4
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value165-160112352372-116-84-90-52-1549
Percentage of StockholdersEquity0.5-0.00.20.00.10.20.10.0-0.4-0.3-0.3-0.2-0.00.2
Percentage of Assets0.2-0.00.10.00.00.10.10.0-0.2-0.1-0.1-0.1-0.00.1
Percentage of Assets us-gaap:AccumulatedGainLossNetCashFlowHedgeParent0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value-6068-4924-5177-4699-4790-4912-4631-4478-3119-3452-3711-3996-4284-4959-4423-4512-4408-4829-2924
Percentage of StockholdersEquity-20.1-15.8-16.3-14.8-15.5-16.1-15.1-14.6-9.9-11.2-11.6-12.6-13.7-24.1-21.3-21.8-21.3-22.8-13.6
Percentage of Assets-9.1-7.3-7.6-6.9-7.1-7.3-6.5-6.5-4.4-4.5-5.1-5.6-6.0-9.4-11.2-11.3-11.1-11.7-7.1
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-312007-12-31
Value3042731301320193189431129307223089830774316013109832218317883154720717208962079520842213262121923126219882163922993237042348925267237872242722683268132710424572255432452624688264692472022476228981751817823
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets45.646.146.746.646.045.743.145.044.640.844.644.744.539.352.952.252.651.750.952.451.052.454.157.256.458.853.952.353.139.942.839.740.940.741.442.740.137.843.741.30.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value-9386-8465-7763-7365-7470-7586-7009-6913-5733-6062-7263-6658-5053-2012-3593-2597-1366854-11632081
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-30.8-27.0-24.2-23.1-24.0-24.7-22.7-22.5-18.1-19.5-35.1-31.2-23.4-8.0-13.4-10.6-6.13.7-6.611.7
Percentage of Assets-14.1-12.5-11.3-10.8-11.0-11.3-9.8-10.1-8.1-8.0-13.8-16.1-12.2-4.7-5.3-4.3-2.31.6-2.70.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value23731238532377123665234612351223428233172322323206130271273412383120481175498178744825774446104
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest78.076.274.274.275.476.575.875.873.574.662.959.757.247.743.840.038.936.142.534.2
Percentage of Assets35.535.134.734.634.735.032.734.132.830.424.730.930.028.017.516.314.715.817.50.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value20921320220820419819319720220117911511396928688433945
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.70.70.60.70.70.60.60.60.60.60.90.50.50.40.30.40.40.20.20.3
Percentage of Assets0.30.30.30.30.30.30.30.30.30.30.30.30.30.20.10.10.10.10.10.0
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value2578625847254402504524613245602414424080238562397825565257572287421979241502090718927170541382510805
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest84.782.679.578.579.179.978.178.275.577.1123.4120.8105.787.090.185.284.274.578.960.6
Percentage of Assets38.638.137.136.636.436.633.735.233.631.448.562.455.451.235.934.731.832.532.60.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:TreasuryStockCommon



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value-9913-10147-9631-9659-9679-9962-9858-9907-9947-10225-10791-10622-8678-6844
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-32.6-32.4-30.1-30.3-31.1-32.4-31.9-32.2-31.5-32.9-52.1-49.8-40.1-27.1
Percentage of Assets-14.8-14.9-14.1-14.1-14.3-14.8-13.8-14.5-14.0-13.4-20.5-25.8-21.0-15.9
Percentage of Assets us-gaap:TreasuryStockCommon0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-06-302011-03-312010-12-312009-12-312008-12-31
Value23731238532377123665234612351223428233172322323206231182301222886130271293912835127441273412641125661246212383122071212612032120481175590058842874482577444
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets35.535.134.734.634.735.032.734.132.830.432.032.332.324.732.832.232.230.930.328.528.930.028.729.228.928.017.514.514.314.715.817.5

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value25786258472544025045246132456024144240802385623978253202520225387255652516225884256542575725375251622474022874223352213722005219792166820318200622415023326222272131420907200522050919323189271705413825
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets38.638.137.136.636.436.633.735.233.631.435.035.435.848.563.765.064.762.460.857.057.455.452.553.452.851.249.147.447.035.936.935.934.134.733.633.131.331.832.532.6

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value-9386-8465-7763-7365-7470-7586-7009-6913-5733-6062-6116-6250-6532-7263-6533-7223-6851-6658-7211-5004-5607-5053-2975-1952-1934-2012-2956-3226-2894-3593-2755-3543-1941-2597-860577182-1366854-1163
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-14.1-12.5-11.3-10.8-11.0-11.3-9.8-10.1-8.1-8.0-8.5-8.8-9.2-13.8-16.5-18.1-17.3-16.1-17.3-11.3-13.0-12.2-7.0-4.7-4.6-4.7-6.7-7.5-6.8-5.3-4.4-5.7-3.1-4.3-1.40.90.3-2.31.6-2.7

Treasury Stock Value

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value20921320220820419819319720220118618618517912012012011510811811411310510299969191959290858986859090884339
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.20.20.20.20.20.20.20.10.10.10.10.10.10.10.10.10.10.1

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value7157121108574-932336460222420111522
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.39.415.09.1-1.90.06.48.623.522.219.8

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value-393-396-238-6154226-205-595-2108-4891-2301-7658
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.1-5.3-3.2-97.14.6-4.2-11.3-39.2-51.7-25.5-99.5

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value-735-1142-6455-4399-1432-550-1152-4732165-684-520
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.5-15.2-87.3-69.4-29.3-11.2-22.0-88.01.7-7.6-6.8

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value7157121108574-932336460222420111522
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.39.415.09.1-1.90.06.48.623.522.219.8

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
Value56410499601006672654563733418-828603283419798-32961531676758078422929055384663755899664765451053194317251242
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.312.611.912.68.98.47.49.45.7-10.98.84.36.615.0-6.211.56.514.811.315.246.816.910.58.47.210.418.08.710.19.719.917.613.1

us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value5649601006672563733418
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.311.912.68.97.49.45.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.0

Profit Loss

us-gaap:ProfitLoss



Period End2020-03-312019-03-312018-03-312017-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
Value5646724184191053194217241242161830319428631440890129110031538148012881438153610841322937
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.38.95.76.69.719.917.613.115.63.120.29.614.510.314.613.017.519.117.221.419.314.518.113.9

Depreciation Depletion And Amortization

Increase Decrease In Other Operating Capital Net

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value369483182-1011261-23054848969217458
Percentage of IncreaseDecreaseInOtherOperatingCapitalNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Inventories

us-gaap:IncreaseDecreaseInInventories



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value4372861711629512890131170-4449
Percentage of IncreaseDecreaseInInventories100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value-393-396-238-6154226-205-595-2108-4891-2301-7658
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.1-5.3-3.2-97.14.6-4.2-11.3-39.2-51.7-25.5-99.5

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value360335275272243235255274453391245
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value-735-1142-6455-4399-1432-550-1152-4732165-684-520
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.5-15.2-87.3-69.4-29.3-11.2-22.0-88.01.7-7.6-6.8

Proceeds From Issuance Of Long Term Debt

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312012-03-312011-03-312010-03-31
Value150059792505710545001
Percentage of RepaymentsOfLongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.0

Payments Of Dividends

Payments Of Dividends Common Stock

us-gaap:PaymentsOfDividendsCommonStock



Period End2020-03-312019-03-312018-03-312017-03-312016-03-31
Value638565491460385
Percentage of PaymentsOfDividendsCommonStock100.0100.0100.0100.0100.0

Payments Of Dividends

Payments For Repurchase Of Common Stock

us-gaap:PaymentsForRepurchaseOfCommonStock



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value236217128955191346219292598771861
Percentage of PaymentsForRepurchaseOfCommonStock100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312012-03-312011-03-312010-03-31
Value150059792505710545001
Percentage of RepaymentsOfLongTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.0

Debt Instrument Interest Rate Stated Percentage

Effective Income Tax Rate Continuing Operations

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

Share Based Compensation

us-gaap:ShareBasedCompensation



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value233226212171152148119125197175173
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Liabilities

Deferred Tax Assets Net

Unrecognized Tax Benefits

Deferred Tax Assets Valuation Allowance

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

Operating Lease Right Of Use Asset

Cash And Cash Equivalents Period Increase Decrease

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value33773860409131373022384473693065385794071101296758706186205001
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Proceeds From Repayments Of Short Term Debt

us-gaap:ProceedsFromRepaymentsOfShortTermDebt



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value51136-1455-583-1471121322481399396775
Percentage of ProceedsFromRepaymentsOfShortTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Proceeds From Sale Of Longterm Investments

abt:AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-31
Value561484483486544562584501392522140145144151151156132161174196196199195194209
Percentage of AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems

us-gaap:MaterialReconcilingItems



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value561484483486544562584501392522140145144151151156132161174146197199
Percentage of AmortizationOfIntangibleAssetsExcludingDiscontinuedOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.074.2100.199.8

us-gaap:ConsolidationItems

abt:CorporateAndBenefitPlanCosts

us-gaap:MaterialReconcilingItems



Period End2020-03-312019-09-302019-03-312018-09-30
Value132131102143
Percentage of CorporateAndBenefitPlanCosts100.0100.0100.0100.0

us-gaap:StatementEquityComponents

abt:EffectOfCommonAndTreasuryShareTransactions

us-gaap:RetainedEarnings



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value-21-565141462
Percentage of EffectOfCommonAndTreasuryShareTransactions100.0100.0100.0100.0100.0100.0100.0

abt:IncomeLossFromContinuingOperationsAllocatedToCommonShares



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value5419541000668548714406558269384-35759755593783526438458337640473541
Percentage of IncomeLossFromContinuingOperationsAllocatedToCommonShares100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations

us-gaap:NoncontrollingInterest



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value-4-646-4-51
Percentage of NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems

abt:OtherCostAndExpenseOperatingAndNonoperating

us-gaap:MaterialReconcilingItems



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value168157100227376238213285607-286109291598225-10842263164222198133139
Percentage of OtherCostAndExpenseOperatingAndNonoperating100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RestructuringCostAndReserve

abt:RestructuringReservePeriodCashSettledAndOtherAdjustments

abt:RestructuringPlanBusinessAcquisitionSt.JudeAndAlereInc.



Period End2020-03-31
Value18
Percentage of RestructuringReservePeriodCashSettledAndOtherAdjustments100.0

abt:RestructuringPlanStreamlineOperations



Period End2020-03-31
Value8
Percentage of RestructuringReservePeriodCashSettledAndOtherAdjustments44.4

us-gaap:ConsolidationItems

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:MaterialReconcilingItems



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value233941142268310121275921714962152435714839491194352126
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AmortizationOfIntangibleAssets



Period End2020-03-312019-03-312018-03-312017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value561486584522140145144151151156174199389391275
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value4004000591255005004115113616063666629
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect



Period End2020-03-312019-03-312018-03-312017-03-31
Value-483-822-5550-9914
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0

us-gaap:CommonStockDividendsPerShareDeclared



Period End2020-03-312019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value0.360.320.280.280.280.2650.2650.2650.260.260.260.240.240.240.220.220.220.140.140.140.510.510.510.480.480.480.440.440.44
Percentage of CommonStockDividendsPerShareDeclared100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value-8000000.0-6000000.0-5000000.0-6000000.0-8000000.0-9000000.0-8000000.0-6000000.0-6000000.0-6000000.0
Percentage of DefinedBenefitPlanAmortizationOfGainsLosses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value-63000000.0-33000000.0-33000000.0-33000000.0-51000000.0-49000000.0-54000000.0-41000000.0-40000000.0-42000000.0
Percentage of DefinedBenefitPlanAmortizationOfGainsLosses787.5550.0660.0550.0637.5544.4675.0683.3666.7700.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value-7-8-8-8-11-12-11-11-12-11
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanContributionsByEmployer

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-03-312018-03-312017-03-31
Value32031314283
Percentage of DefinedBenefitPlanContributionsByEmployer100.0100.0100.0100.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value7677988988
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value192177178178169171171154153152
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets2742.92950.02542.92542.91877.82137.52137.51711.11912.51900.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanInterestCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value12131313121212121111
Percentage of DefinedBenefitPlanInterestCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value75848584777778727172
Percentage of DefinedBenefitPlanInterestCost625.0646.2653.8646.2641.7641.7650.0600.0645.5654.5

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value1810910778435
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value31323352339302834
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost172.230.022.230.0500.0328.6487.5750.0933.3680.0

us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanServiceCost

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value12566767667
Percentage of DefinedBenefitPlanServiceCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PensionPlansDefinedBenefit



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-31
Value85636164766778717072
Percentage of DefinedBenefitPlanServiceCost708.31260.01016.71066.71085.71116.71114.31183.31166.71028.6

us-gaap:Depreciation



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value267267268252203215224221354354287
Percentage of Depreciation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:DividendsCommonStockCash

us-gaap:RetainedEarnings



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value641570568568495495493
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations



Period End2020-03-312019-03-312018-03-31
Value-70435
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations100.0100.0100.0

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense



Period End2020-03-312019-03-312018-03-31
Value476565
Percentage of EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense100.0100.0100.0

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value-5-74-6-116361216-9-10-47814-5541-1-2-4-10-28614-24510322040-70
Percentage of ForeignCurrencyTransactionGainLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccountsReceivable



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value10417053-30490-829-132-298-291
Percentage of IncreaseDecreaseInAccountsReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value11121213121111108756910101110141416171716159968713
Percentage of IncrementalCommonSharesAttributableToShareBasedPaymentArrangements100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems

us-gaap:InterestIncomeExpenseNet

us-gaap:MaterialReconcilingItems



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value-121-143-146-148-181-189-199-182-183-204-95-83-25-16-17-16-17-2023-21-2326
Percentage of InterestIncomeExpenseNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InvestmentIncomeInterest



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-09-302011-06-302011-03-312010-09-302010-06-302010-03-31
Value18242223222128363122222033252721181916161615182017201821153829
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value-57-31-26-23-22-61-23-23-29-34-1547-18
Percentage of OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-31
Value-1144-47891122-153-135933328528853389-104421
Percentage of OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-312019-09-302019-06-302019-03-312018-06-302018-03-312016-06-302013-09-302013-03-31
Value773-130-10-62-8-69
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value17667-2-171081-52-44-38
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax2514.3957.1-66.71700.00.0270.0520.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value-1144-47891122-153-135933328528853389-104421-64584-911-1096-1962270-360-391
Percentage of OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax-16342.9-6828.63033.3-12200.00.0-4530.0-3330.00.00.00.00.0167.70.00.00.00.00.00.00.0-3375.00.0566.7

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value16649-12-2935118
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value4823-7-81648
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax

us-gaap:Debt, us-gaap:NetInvestmentHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-31
Value-8
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:ForeignExchangeForward, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:CostOfSales



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value22799-2-1918113
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax-2837.50.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-31
Value-921-398105116-96-1180324134282582690-372-193-2207603-681
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-30
Value5731262322612323293415-47182622311612161828-413240
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent-6.2-7.824.819.8-22.9-5.27.117.210.35.82.212.6-9.3-1.23.6-4.60.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value16649-12-2935118-32-38-37
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent-18.0-12.3-11.4-25.0-36.5-10.0-9.9-28.4-13.1

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value-921-398105116-96-1180324
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-30
Value-1144-47891122-153-135933328528853389-104421-64584-911-1096-1962270-360-391515-1126
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent124.2120.186.7105.2159.4115.2102.8212.7102.191.612.928.0-218.129.213.9133.80.00.00.00.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-31
Value-15-7-7-7-16-15-17-11-11-128-129141015778815-25182222
Percentage of OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsForOtherTaxes



Period End2020-03-312019-03-312018-03-312017-03-31
Value125185220160
Percentage of PaymentsForOtherTaxes100.0100.0100.0100.0

us-gaap:PaymentsForProceedsFromInvestments



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312012-03-312011-03-312010-03-31
Value36-2515-44621338991917-874
Percentage of PaymentsForProceedsFromInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsForProceedsFromOtherInvestingActivities



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312012-03-312011-03-312010-03-31
Value-3-15-42-32-13-27-11-72
Percentage of PaymentsForProceedsFromOtherInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromStockOptionsExercised



Period End2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Value891271371298715617068687175188
Percentage of ProceedsFromStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax

us-gaap:ForeignExchangeForward, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:CostOfSales



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value11261715-37-53
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax100.0100.0100.0100.0100.0100.0

us-gaap:InterestRateSwap, us-gaap:FairValueHedging, us-gaap:DesignatedAsHedgingInstrument, us-gaap:InterestExpense



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-30
Value168359643-42-31
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax1527.3134.6564.7286.7113.558.5

us-gaap:HedgingDesignation

us-gaap:Nondesignated



Period End2020-03-312019-09-302019-03-312018-09-30
Value-1654949-10
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax-1500.0188.5326.727.0

us-gaap:StatementEquityComponents

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

us-gaap:AccumulatedDefinedBenefitPlansAdjustment



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value-50-24-23-24-22-31-33-23-29-34-15-15-18-26-22-31-16-12-16-26-28-28
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-30
Value10181012-25-37-20-6-1
Percentage of ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax-20.0-75.0-43.5-50.0113.6119.460.626.13.4

us-gaap:IncomeStatementLocation, us-gaap:RestructuringCostAndReserve

us-gaap:RestructuringCharges

us-gaap:CostOfSales, abt:RestructuringPlanBusinessAcquisitionSt.JudeAndAlereInc.



Period End2020-03-31
Value3
Percentage of RestructuringCharges100.0

us-gaap:CostOfSales, abt:RestructuringPlanStreamlineOperations



Period End2020-03-31
Value1
Percentage of RestructuringCharges33.3

us-gaap:ResearchAndDevelopmentExpense, abt:RestructuringPlanBusinessAcquisitionSt.JudeAndAlereInc.



Period End2020-03-31
Value1
Percentage of RestructuringCharges33.3

us-gaap:ResearchAndDevelopmentExpense, abt:RestructuringPlanStreamlineOperations



Period End2020-03-31
Value1
Percentage of RestructuringCharges33.3

us-gaap:SellingGeneralAndAdministrativeExpenses, abt:RestructuringPlanBusinessAcquisitionSt.JudeAndAlereInc.



Period End2020-03-31
Value5
Percentage of RestructuringCharges166.7

us-gaap:SellingGeneralAndAdministrativeExpenses, abt:RestructuringPlanStreamlineOperations



Period End2020-03-31
Value21
Percentage of RestructuringCharges700.0

us-gaap:RestructuringCostAndReserve

abt:RestructuringPlanBusinessAcquisitionSt.JudeAndAlereInc.



Period End2020-03-31
Value9
Percentage of RestructuringCharges300.0

abt:RestructuringPlanStreamlineOperations



Period End2020-03-31
Value23
Percentage of RestructuringCharges766.7

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

us-gaap:TreasuryStockCommon



Period End2020-03-312019-03-31
Value56
Percentage of StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures100.0100.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised

us-gaap:CommonStock



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value1022103
Percentage of StockIssuedDuringPeriodSharesStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures

us-gaap:CommonStock



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value-420-5-13-364-5-6-310
Percentage of StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStockCommon



Period End2020-03-312019-03-31
Value253303
Percentage of StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures-60.2-83.2

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation

us-gaap:CommonStock



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value245931062378390225
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised

us-gaap:CommonStock



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value5318111763310102
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementOperatingActivitiesSegment

us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions

us-gaap:SegmentDiscontinuedOperations



Period End2020-03-31
Value-20
Percentage of TaxAdjustmentsSettlementsAndUnusualProvisions100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockSharesAcquired

us-gaap:TreasuryStockCommon



Period End2020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-31
Value0000000
Percentage of TreasuryStockSharesAcquired100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockValueAcquiredCostMethod

us-gaap:TreasuryStockCommon



Period End2020-03-312019-06-302019-03-312018-06-302018-03-31
Value19120114
Percentage of TreasuryStockValueAcquiredCostMethod100.0100.0100.0100.0100.0

abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value87389062839084898523808086798867914390308785875089304549
Percentage of PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:PrepaidExpenseAndOtherReceivables



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value19701786194219191718155915821935172016671895191219641806
Percentage of PrepaidExpenseAndOtherReceivables100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccountsPayableTradeCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value318132523029322230452975273025032476240218581667148111781051115310531081100710001012106496510621074102610081042108717961605151917261721160114481577153512801351
Percentage of AccountsPayableTradeCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value348335402646267727032726241524372498252121922215-2244-2284-1972-1987-1940-1958-2131-2157-2179-2229-1268-1284-1296-1312-2389-2408243635952618265026902730213921672190222021611901
Percentage of AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value-6068-4924-5177-4699-4790-4912-4631-4478-3119-3452-3711-3996-4284-4959-4423-4512-4408-4829-4288-3643-3727-2924-1771-675-656-718-617-887527792471067-586721223271823617443035740
Percentage of AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivable



Period End2020-03-312019-12-31
Value241228
Percentage of AllowanceForDoubtfulAccountsReceivable100.0100.0

us-gaap:Restatement, us-gaap:AdjustmentsForNewAccountingPronouncements

srt:RestatementAdjustment, us-gaap:AccountingStandardsUpdate201613



Period End2020-03-31
Value7
Percentage of AllowanceForDoubtfulAccountsReceivable2.9

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value389384354338331314326319321294279265263250284347350337358362317310332354324312340309321405417375422420470432406388311263
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax



Period End2020-03-312019-12-312019-09-302019-06-302018-12-312017-12-31
Value165-1601152-84
Percentage of AociLossCashFlowHedgeCumulativeGainLossAfterTax100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AssetsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302010-12-312009-12-31
Value304357341332340320363353379374992118314112676267530303245378028171099326626176771068993767575
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302010-12-312009-12-31
Value5801963722181531141302386613822021224128436140140229537951326628364280171229275305890814697878792271111
Percentage of AssetsFairValueDisclosure190.854.9109.165.745.035.635.867.417.436.922.217.917.110.613.513.212.47.813.551320.073644.44044.49333.3657.7369.4450.8401.31155.8767.9783.1944.11042.1361.3148.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value884553713550493434493591445512121213951652296030363431364740753196373
Percentage of AssetsFairValueDisclosure290.8154.9209.1165.7145.0135.6135.8167.4117.4136.9122.2117.9117.1110.6113.5113.2112.4107.8113.54144.4

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AvailableForSaleSecurities

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-31
Value304357341332340320363353379374992118314112676267530303245378028171099326
Percentage of AvailableForSaleSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value304357341332340320363353379374992118314112676267530303245378028179
Percentage of AvailableForSaleSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:BusinessCombinationContingentConsiderationLiability

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-31
Value6768687670717112511912013014620313616316216117318016925024378208
Percentage of BusinessCombinationContingentConsiderationLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value67686876707171125119120130146203136163162161173180243
Percentage of BusinessCombinationContingentConsiderationLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiability



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value305294295297282259252257239198
Percentage of ContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Range

us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible

srt:Maximum



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value520510430430430350700700
Percentage of DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible100.0100.0100.0100.0100.0100.0100.0100.0

srt:Minimum



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value230220185185185125500500
Percentage of DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible44.243.143.043.043.035.771.471.4

us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value339030793210313630271868211020052082194415651552177922632119
Percentage of DeferredIncomeTaxesAndOtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeFairValueOfDerivativeAsset



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value58019637221815311413023866138220212241284361401402295379460594358280177147171214229275305890814697878695223222271111318
Percentage of DerivativeFairValueOfDerivativeAsset100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

abt:DeferredIncomeTaxesAndOtherAssets, us-gaap:InterestRateSwap, us-gaap:FairValueHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302017-06-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-31
Value2164874397821126121711617210315010110087
Percentage of DerivativeFairValueOfDerivativeAsset37.224.519.917.93.32.858.465.154.039.345.422.425.328.235.750.9

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

abt:PrepaidExpensesAndOtherReceivables, us-gaap:ForeignExchangeForward, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value247110244116111816155921232999
Percentage of DerivativeFairValueOfDerivativeAsset42.656.165.653.272.571.146.923.113.615.210.513.734.9

abt:PrepaidExpensesAndOtherReceivables, us-gaap:ForeignExchangeForward, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-31
Value11738546342336918357117197176177
Percentage of DerivativeFairValueOfDerivativeAsset20.219.414.528.927.528.953.176.986.484.889.583.062.3

us-gaap:DerivativeFairValueOfDerivativeLiability



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value7436359579146195368391425298282256200610678677688541567523559575647547572580626709695841867788708861768686760816907685
Percentage of DerivativeFairValueOfDerivativeLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:LongTermDebt, us-gaap:Debt, us-gaap:NetInvestmentHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-31
Value554546
Percentage of DerivativeFairValueOfDerivativeLiability74.686.0

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:AccruedLiabilities, us-gaap:ForeignExchangeForward, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-30
Value925633463644193313410611185511597856318209
Percentage of DerivativeFairValueOfDerivativeLiability12.48.834.758.224.722.65.28.431.535.639.433.225.52.514.312.69.23.33.51.7

us-gaap:AccruedLiabilities, us-gaap:ForeignExchangeForward, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-31
Value97336233535177128929911811257675976154841056610713015975
Percentage of DerivativeFairValueOfDerivativeLiability13.15.265.341.836.326.220.932.721.633.241.843.828.511.08.711.222.415.518.512.619.122.624.612.9

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:DerivativeNotionalAmount

us-gaap:ForeignExchangeForward, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-312019-12-312019-09-302018-12-31
Value7000680063005100
Percentage of DerivativeNotionalAmount100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeForward, us-gaap:Nondesignated



Period End2020-03-312019-12-312019-09-302018-12-31
Value950091001040013600
Percentage of DerivativeNotionalAmount135.7133.8165.1266.7

us-gaap:EmployeeRelatedLiabilitiesCurrent



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312010-12-312009-12-31
Value949123712581018886118212411034949118711039058027527997176067468547596497768678286819068888007331427139512251021126013281117
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount



Period End2020-03-312019-12-312019-09-302019-06-30
Value162158155160
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value1230011900112001110010800104009800930087008100750070006600620061006000580057005300510050004900450070006900680066006400610097009400910086008300780073006900650051004200
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FiniteLivedIntangibleAssetsGross



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value2730027600251002560025700257002570025600258002560022400217002110010400105001090010900108001080010800109001100010500123001240012200120001180011900176001760017300176001750017700181001760017300108009400
Percentage of FiniteLivedIntangibleAssetsGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value364148298179114
Percentage of ForeignCurrencyCashFlowHedgeAssetAtFairValue100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value364148298179114
Percentage of ForeignCurrencyCashFlowHedgeAssetAtFairValue100.0100.0100.0100.0100.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value364148298179114
Percentage of ForeignCurrencyCashFlowHedgeAssetAtFairValue100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value364148298179114
Percentage of ForeignCurrencyCashFlowHedgeAssetAtFairValue100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value18989957995
Percentage of ForeignCurrencyCashFlowHedgeLiabilityAtFairValue100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementBasis

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value18989957995
Percentage of ForeignCurrencyCashFlowHedgeLiabilityAtFairValue100.0100.0100.0100.0100.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value18989957995
Percentage of ForeignCurrencyCashFlowHedgeLiabilityAtFairValue100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302018-12-31
Value18989957995
Percentage of ForeignCurrencyCashFlowHedgeLiabilityAtFairValue100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:HedgedLiabilityFairValueHedge

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302018-12-31
Value3064289029272743
Percentage of HedgedLiabilityFairValueHedge100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302018-12-31
Value3064289029272743
Percentage of HedgedLiabilityFairValueHedge100.0100.0100.0100.0

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-31
Value120013003600360036003600360036003800390037004000490034932539040341937713413413411411411426652025827569176477977881490090015001400610
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:InterestRateDerivativeAssetsAtFairValue

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302017-06-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302010-12-312009-12-31
Value216487439782112612171161721031501011008710417518575968158859861614680
Percentage of InterestRateDerivativeAssetsAtFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302017-06-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value21648743978211261217116172101
Percentage of InterestRateDerivativeAssetsAtFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementBasis

us-gaap:InterestRateFairValueHedgeAssetAtFairValue

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302017-06-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value21648743978211261217116172103150101100106988787185
Percentage of InterestRateFairValueHedgeAssetAtFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302017-06-302016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value21648743978211261217116172103150101100106988787185
Percentage of InterestRateFairValueHedgeAssetAtFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryFinishedGoodsNetOfReserves



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value287327842846278626412407234022642424233922732355270416241744
Percentage of InventoryFinishedGoodsNetOfReserves100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryRawMaterialsNetOfReserves



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value1080972962982908890880887866790754798782516539
Percentage of InventoryRawMaterialsNetOfReserves100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryWorkInProcessNetOfReserves



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value615560584584536499561563536472456450509294316
Percentage of InventoryWorkInProcessNetOfReserves100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:LiabilitiesFairValueDisclosure

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302010-12-312009-12-31
Value3253297930222961294329384098415442234196422241945595556943944441445942374321419642901772178716981810183398587677757073877608756176105694
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-312013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302010-12-31
Value6768687670717112511912013014620313616316216117318016925024378208195193323313301294423395365
Percentage of LiabilitiesFairValueDisclosure2.12.32.32.62.42.41.73.02.82.93.13.53.62.43.73.63.64.14.24.05.813.74.412.210.810.53.34.14.04.05.65.24.8

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value33203047309030373013300941694279434243164352434057985705455746034620441045012015
Percentage of LiabilitiesFairValueDisclosure102.1102.3102.3102.6102.4102.4101.7103.0102.8102.9103.1103.5103.6102.4103.7103.6103.6104.1104.2113.7

us-gaap:FairValueByMeasurementBasis

us-gaap:LongTermDebtFairValue

us-gaap:CarryingReportedAmountFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value1806817938188931899018853193662334720329216612771823814238132376720684597960205980587459855894598234633925341233953397339718394
Percentage of LongTermDebtFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EstimateOfFairValueFairValueDisclosure



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302012-12-31
Value2099820772215252126420311198712401320841224362901825166250072434921147666567126621633764936323674941134505403339183930393019588
Percentage of LongTermDebtFairValue116.2115.8113.9112.0107.7102.6102.9102.5103.6104.7105.7105.0102.4102.2111.5111.5110.7107.9108.5107.3112.8118.8114.8118.2115.4115.7115.7106.5

us-gaap:Range, us-gaap:LossContingenciesByNatureOfContingency

us-gaap:LossContingencyEstimateOfPossibleLoss

srt:Maximum, abt:LegalProceedingsAndEnvironmentalExposures



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value125130140125140165
Percentage of LossContingencyEstimateOfPossibleLoss100.0100.0100.0100.0100.0100.0

srt:Minimum, abt:LegalProceedingsAndEnvironmentalExposures



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value90951109095125
Percentage of LossContingencyEstimateOfPossibleLoss72.073.178.672.067.975.8

us-gaap:RestructuringCostAndReserve

us-gaap:RestructuringReserve

abt:RestructuringPlanBusinessAcquisitionSt.JudeAndAlereInc.



Period End2020-03-312019-12-31
Value3746
Percentage of RestructuringReserve100.0100.0

abt:RestructuringPlanStreamlineOperations



Period End2020-03-312019-12-31
Value9479
Percentage of RestructuringReserve254.1171.7

us-gaap:StatementBusinessSegments

us-gaap:RevenueRemainingPerformanceObligation

abt:DiagnosticProducts



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value340033003200310030002900280028002900
Percentage of RevenueRemainingPerformanceObligation100.0100.0100.0100.0100.0100.0100.0100.0100.0

abt:MedicalDevices



Period End2020-03-312019-12-31
Value400380
Percentage of RevenueRemainingPerformanceObligation11.811.5

us-gaap:ShortTermBorrowings



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
Value204201204204201200211341230206211218207132225312892261031272370286729214382437639534370316445954259335820813206506337572347358955654718434949781691
Percentage of ShortTermBorrowings100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStockCommonShares



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value209214208208209215214215216222223225225234229
Percentage of TreasuryStockCommonShares100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStockCommonValue



Period End2020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value9913101479631965996799962985899079947102251029010362103791079110622
Percentage of TreasuryStockCommonValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Line plots across dimensions of each concept

us-gaap:CommonStockSharesOutstanding us-gaap:StatementEquityComponents


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments, us-gaap:Subsegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments, us-gaap:Subsegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments, us-gaap:Subsegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments, us-gaap:Subsegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments


us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments, us-gaap:Subsegments


us-gaap:OperatingIncomeLoss us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments


us-gaap:StockholdersEquity us-gaap:StatementEquityComponents


us-gaap:LongTermInvestments us-gaap:InvestmentType


us-gaap:Goodwill us-gaap:StatementBusinessSegments


us-gaap:StockholdersEquity us-gaap:StatementEquityComponents


us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents